US PATENT SUBCLASS 530 / 387.1
.~.~.~ Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed


Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999      Terms of Use



530 /   HD   CHEMISTRY: NATURAL RESINS OR DERIVATIVES; PEPTIDES OR PROTEINS; LIGNINS OR REACTION PRODUCTS THEREOF

350  DF  PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES {14}
380  DF  .~ Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc. {3}
386  DF  .~.~ Globulins {4}
387.1.~.~.~ Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed {9}
387.2  DF  .~.~.~.~> Anti-idiotypic
387.3  DF  .~.~.~.~> Chimeric, mutated, or recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rFv, immunoglobulin fusion protein, etc.)
387.5  DF  .~.~.~.~> Binds oligosaccharide structure
387.7  DF  .~.~.~.~> Binds expression product of cancer-related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.)
387.9  DF  .~.~.~.~> Binds specifically-identified amino acid sequence
388.1  DF  .~.~.~.~> Monoclonal {3}
389.1  DF  .~.~.~.~> Polyclonal antibody or immunogloblin of identified binding specificity {7}
390.1  DF  .~.~.~.~> Removing or inactivating virus or bacterium or component or product thereof (e.g., endotoxin, etc.)
390.5  DF  .~.~.~.~> Removing, dissociating, or preventing the formation of aggregated, denatured, fragmented, or polymerized immunoglobulin or antibody; or preventing or reducing complement fixation or binding; or reducing antigenicity; or removing, inactivating, or inhibiting contaminating plasma proteins (e.g., proteolytic enzymes, etc.)


DEFINITION

Classification: 530/387.1

Immunoglobulin, antibody, or fragment thereof, other than

immunoglobulin, antibody, or fragment thereof that is conjugated or adsorbed:

(under subclass 386) Subject matter in which the protein has the structure of an immunoglobulin, antibody, or fragment thereof that is not conjugated or adsorbed to another substance.

(1) Note. This subclass includes immunoglobulins or gamma globulins (except monoclonal antibodies) whose binding specificities are not disclosed, and methods of purifying immunoglobulins, except those methods provided for in subclasses 390.1 and 390.5. Patents pertaining generically to monoclonal antibodies whose binding specificities are not disclosed are classified in subclasses 388.1 or 388.15.

(2) Note. Immunoglobulins may be monoclonal or polyclonal. Monoclonal antibodies are identical antibody molecules produced by a clone of cells or cell line that is derived from a single antibody-producing cell, or are antibody molecules that have otherwise been made identical. Polyclonal antibodies or immunoglobulins are mixtures of antibodies produced by multiple cells or clones of cells that produce antibody molecules that are not identical to each other, but which may bind different antigenic determinants or epitopes on the same molecule.

(3) Note. Antibodies are assumed to be polyclonal unless they are specifically characterized as being monoclonal, or if they are secreted by a single cell line or cell clone.

(4) Note. The major classes of immunoglobulins are IgG, IgM, IgA, IgD, and IgE. Subclasses of immunoglobulins also exist, notably the IgG1, IgG2a, IgG2b, IgG3, and IgG4 subclasses comprising the IgG class. IgY is similar to IgG and is found only in birds.

(5) Note. Synonyms are immune globulin, gamma globulin, Ig, etc.

SEE OR SEARCH THIS CLASS, SUBCLASS: 391.1+, for antibodies or antisera or fragments thereof that are conjugated or adsorbed to other substances.

407, for methods of hydrolysis of proteins.

828, for cancer-associated proteins.

829, for blood proteins, including immunoglobulins.

830, for plasma or serum proteins, including immunoglobulins.

831, for immunoglobulins and other proteins isolated via the

Cohn fractionation method.

832, for immunoglobulins isolated from milk or colostrum.

833, for immunoglobulins isolated from whey.

851, for immunoglobulins isolated from placental extracts.

SEE OR SEARCH CLASS

424, Drug, Bio-Affecting and Body Treating Compositions, for compositions intended for class defined uses such as in vivo diagnosing (e.g., imaging), methods of making such compositions, and nominal methods of using such compositions, see 1.49+, for compositions comprising radiolabelled antibody, or antibody fragment, or immunoglobulin, subclasses 9.3+ and 9.4+ for testing compositions, and subclasses 130.1+ for body-treating compositions containing an immunoglobulin, an antiserum, an antibody, or an antibody fragment.

435, Chemistry: Molecular Biology and Microbiology,

4+, particularly subclasses 7.1+ for antibodies used in immunological testing involving a microorganism or an enzyme; subclass 188 for antibodies conjugated to enzymes; and subclass 188.5 for catalytic antibodies.

436, Chemistry: Analytical and Immunological Testing,

15, for protein-containing compositions used as standards or controls; subclass 16 for blood standards; subclass 66 for tests for hemoglobin or myoglobin; subclass 69 for tests for blood clotting factors; subclasses 86+ for tests for proteins or peptides, including sequencing methods; subclass 501 for complement binding assays or protein binding assays; and subclasses 506-548 for tests using antigen-antibody interactions in a chemical test, particularly subclasses 543-548, which collect methods of modifying antigens and antibodies as part of a testing procedure.

514, Drug, Bio-Affecting and Body Treating Compositions,

1, 21 and Cross-Reference Art Collections 800-809 which provide for compositions having a Class 424 utility containing a peptide or protein as an organic active ingredient.

525, Synthetic Resins or Natural Rubbers,

54.1, for antibodies chemically bound to synthetic resins.